Developer docs
API playgroundTry for free, no card

Search company profiles

SVAS Biosana

Full company profile

uuid0003d3x

Namestring
SVAS Biosana
Legal namestring
SVAS BIOSANA S.p.A.
Websiteurl
svas.it
Company typeenum
Public
Founded yearint
1972
Descriptiontext

SVAS Biosana S.p.A. is an Italian medical device manufacturer and distributor founded in 1972 and headquartered in the Naples area, with administrative offices in Somma Vesuviana and its legal seat in San Giuseppe Vesuviano. The company designs, manufactures, and distributes a diversified portfolio of medical devices organized into five sub-brands: FARMEX (incontinence aids, cotton, personal care), SVAS (peritoneal dialysis products, Closed System Transfer Device for hazardous drug transfer, surgical instrument kits), MEDICAL (custom procedure packs, drapes, advanced wound dressings, gel-based medical devices), MARK MEDICAL (orthopedic prostheses, stents, angiographic guides, heart valves, contrast agents and injectors), and BORMIA (medical devices for cardiac and vascular surgery, anesthesiology, intensive care, endovascular procedures, and neuroradiology). Operations span three Italian production sites, with a workforce of approximately 400 employees supporting direct B2B sales to hospitals, clinics, and healthcare providers across Italy and through eight corporate sites abroad, including recently acquired Serbian distributors.

The company operates proprietary digital infrastructure supporting its distribution model: the SVAS myDDT mobile application manages courier deliveries (borderò, digital DDT signatures, offline operation with sync), while the patient-facing SVAS myCare app enables healthcare supply tracking, prescription authorization viewing, and delivery monitoring, both integrated with the mySAD Web backend via REST APIs. SVAS holds a broad certification stack including ISO 9001, ISO 13485, ISO 45001, ISO 27001, ISO 14001, ISO 37001, ISO 50001, UNI PDR 125:2022 (gender equality), and GDPR compliance under a designated DPO.

Commercially, SVAS earns revenue primarily through one-time sales of medical devices to healthcare institutions via a direct sales force and acquired regional distributors; pricing is quote-based and not publicly disclosed. The company followed a deliberate capital-markets trajectory — Elite Project (2012), inaugural basket bond (2017), Euronext Growth Milan IPO (December 9, 2021) — and in March 2025 executed its first major international M&A, acquiring Belgrade-based medical device distributors Hermes Pharma and Megapharm for a combined EUR 7 million to expand Serbian market presence.

Short descriptiontext

Italian medical device manufacturer and distributor founded in 1972 and listed on Euronext Growth Milan. Produces incontinence aids, dialysis products, surgical instruments, advanced wound care, and cardiovascular devices across five sub-brands for hospitals, clinics, and home-care patients via ~400 employees.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
101–250
akta.pro rankint
HeadquartersSomma Vesuviana, Italy
HQ citystring
Somma Vesuviana
HQ countrystring
Italy
HQ regionstring
Europe
Markets served

Serves global market

Offices3 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
medical devices manufacturing, pharmaceutical products, peritoneal dialysis supplies, surgical instruments, wound care dressings
Industry3 codes
PRIMARYHSABAKAH
Incontinence & Urological Supplies (Catheters, Briefs, Ostomy Supplies)
Home & Personal Services/Elder Care & In-Home Care Services/Medical Equipment & Home Mobility Support Services
SECONDARYCRADALAF
Adult Incontinence Products
Consumer Products & Retail/Consumer Packaged Goods (CPG) Manufacturing & Brands/Paper Goods & Disposables (Tissue, Diapers, Feminine Care)
SECONDARYCRADAMAK
Personal Medical Devices & Home Diagnostics (Thermometers, Blood Pressure Monitors, Glucose Meters, Rapid Tests)
Consumer Products & Retail/Consumer Packaged Goods (CPG) Manufacturing & Brands/Health & Hygiene OTC Consumer Goods (First Aid, Oral Care, Personal Health)
NAICS code2 codes
  • Surgical and Medical Instrument Manufacturing339112
  • Surgical Appliance and Supplies Manufacturing339113
SIC code2 codes
  • Surgical & Medical Instruments & Apparatus3841
  • Orthopedic, Prosthetic & Surgical Appliances & Supplies3842
Product category
Medical Devices
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Medical Devices Manufacturing and Distribution
TypeOne Time License
Description

Production and distribution of medical devices across multiple product lines including incontinence aids, dialysis products, surgical instruments, orthopedic devices, and advanced wound care products to healthcare providers

svas.it
Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels2 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales, Infrastructure
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 5 records shown
1FARMEX
Description

Incontinence aids, medical treatments, cotton and personal care products

svas.it
+4 more records
Core offering1 text field

SVAS Biosana plans, manufactures, and markets medical devices and pharmaceutical products across five business lines covering incontinence aids, peritoneal dialysis products, custom surgical packs and advanced wound dressings, cardiovascular implants and contrast agents, and cardiac/vascular surgery devices. The company operates three production sites in Italy and distributes medical devices to healthcare providers in Italy and international markets, supplemented by proprietary mobile applications (SVAS myDDT for courier management and SVAS myCare for patient delivery tracking).

Differentiator
Functional benefit
Problem solved
Product overview1 text field

SVAS Biosana is a multi-brand medical device company comprising five product sub-brands — FARMEX (incontinence aids and personal care), SVAS (peritoneal dialysis and drug transfer devices), MEDICAL (custom surgical packs and advanced dressings), MARK MEDICAL (cardiovascular implants and contrast agents), and BORMIA (cardiac/vascular surgery and neuroradiology devices) — complemented by two digital mobile applications (SVAS myDDT for courier delivery management and SVAS myCare for patient delivery tracking), all integrated through the mySAD Web backend system. The company also operates two acquired Serbian distributors (Hermes Pharma and Megapharm) following its EUR 7 million acquisition in March 2025. SVAS Biosana listed on Euronext Growth Milan in December 2021 and operates 3 production sites in Italy with a workforce of approximately 400 employees across multiple countries.

Product and service1 record
1FARMEX
Scale indicator5 records

Each record includes

Type, Value, Description, Source

Partnership2 partners
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2025-03-25
Description

Serbian medical device distributor based in Belgrade, acquired by Svas Biosana for EUR 3.75 million. Part of strategic expansion in Serbian market.

2Megapharm
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2025-03-25
Description

Serbian medical device distributor based in Belgrade, acquired by Svas Biosana for EUR 3.25 million. Part of strategic expansion in Serbian market.

ekapija.com
Recent move7 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

German medical and hygiene products company with strong positions in wound care, incontinence management, and surgical supplies. Comparable to SVAS Biosana across multiple product lines and in European mid-tier medical device distribution.

TypeDirect peer
Description

European renal care services and dialysis products provider operating across multiple countries. Comparable to SVAS Biosana's peritoneal dialysis offering and represents a potential cross-border partner or competitor in the European dialysis device market.

TypeBroad incumbent
Description

Global medical technology company with a broad portfolio of medical devices, surgical instruments, and injection systems. Comparable to SVAS Biosana in serving hospitals and healthcare providers with multi-category device offerings, though at substantially greater scale and with deeper international reach.

TypeDirect peer
Description

Danish medical device company specializing in ostomy, continence, wound care, and skin health products. Directly comparable to SVAS Biosana's FARMEX incontinence and MEDICAL wound care lines, with overlapping chronic-care customer segments and similar European hospital distribution model.

TypeDirect peer
Description

UK-based medical products company focused on advanced wound care, ostomy, continence, and infusion care. Closely comparable to SVAS Biosana's FARMEX and MEDICAL sub-brands, particularly in incontinence and advanced wound dressings sold through hospital and home-care channels.

TypeBroad incumbent
Description

Swedish medical device company specializing in wound care and surgical solutions. Comparable to SVAS Biosana's MEDICAL sub-brand (advanced wound dressings and surgical packs) and shares a similar European mid-market hospital sales motion.

TypeBroad incumbent
Description

Global medical technology company with portfolios in advanced wound management, orthopedics, and sports medicine. Comparable to SVAS Biosana's MARK MEDICAL orthopedic prosthesis line and MEDICAL wound care products, though operating at multinational scale.

TypeBroad incumbent
Description

Global medical device leader with significant exposure to cardiovascular, cardiac surgery, and endovascular procedures. Comparable to SVAS Biosana's BORMIA (cardiac/vascular surgery, neuroradiology) and MARK MEDICAL (stents, heart valves) sub-brands, though operating at vastly greater scale and clinical evidence depth.

TypeBroad incumbent
Description

Global leader in dialysis products and services. Comparable to SVAS Biosana's SVAS sub-brand for peritoneal dialysis products, though at global scale with vertically integrated dialysis clinic operations.

TypeRegional player
Description

Italian consumer health and personal care company (parent of Chicco, Pic Solution, and Lycia). Comparable as an Italian-headquartered healthcare products company with personal care and medical device adjacencies overlapping with SVAS Biosana's FARMEX incontinence and personal care lines.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers1 record

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment2 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature5 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles2 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries2 records

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

Compliance9 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds2 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors1 record

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A1 record

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

SVAS Biosana

Medical Devicessvas.it

Italian medical device manufacturer and distributor founded in 1972 and listed on Euronext Growth Milan. Produces incontinence aids, dialysis products, surgical instruments, advanced wound care, and cardiovascular devices across five sub-brands for hospitals, clinics, and home-care patients via ~400 employees.

What SVAS Biosana does

SVAS Biosana S.p.A. is an Italian medical device manufacturer and distributor founded in 1972 and headquartered in the Naples area, with administrative offices in Somma Vesuviana and its legal seat in San Giuseppe Vesuviano. The company designs, manufactures, and distributes a diversified portfolio of medical devices organized into five sub-brands: FARMEX (incontinence aids, cotton, personal care), SVAS (peritoneal dialysis products, Closed System Transfer Device for hazardous drug transfer, surgical instrument kits), MEDICAL (custom procedure packs, drapes, advanced wound dressings, gel-based medical devices), MARK MEDICAL (orthopedic prostheses, stents, angiographic guides, heart valves, contrast agents and injectors), and BORMIA (medical devices for cardiac and vascular surgery, anesthesiology, intensive care, endovascular procedures, and neuroradiology). Operations span three Italian production sites, with a workforce of approximately 400 employees supporting direct B2B sales to hospitals, clinics, and healthcare providers across Italy and through eight corporate sites abroad, including recently acquired Serbian distributors.

The company operates proprietary digital infrastructure supporting its distribution model: the SVAS myDDT mobile application manages courier deliveries (borderò, digital DDT signatures, offline operation with sync), while the patient-facing SVAS myCare app enables healthcare supply tracking, prescription authorization viewing, and delivery monitoring, both integrated with the mySAD Web backend via REST APIs. SVAS holds a broad certification stack including ISO 9001, ISO 13485, ISO 45001, ISO 27001, ISO 14001, ISO 37001, ISO 50001, UNI PDR 125:2022 (gender equality), and GDPR compliance under a designated DPO.

Commercially, SVAS earns revenue primarily through one-time sales of medical devices to healthcare institutions via a direct sales force and acquired regional distributors; pricing is quote-based and not publicly disclosed. The company followed a deliberate capital-markets trajectory — Elite Project (2012), inaugural basket bond (2017), Euronext Growth Milan IPO (December 9, 2021) — and in March 2025 executed its first major international M&A, acquiring Belgrade-based medical device distributors Hermes Pharma and Megapharm for a combined EUR 7 million to expand Serbian market presence.

SVAS Biosana firmographics

Firmographics
Name
SVAS Biosana
Legal name
SVAS BIOSANA S.p.A.
Website
https://svas.it
Company type
Public
Founded year
1972
Operating status
Operating
Headcount range
101–250 employees
Short description
Italian medical device manufacturer and distributor founded in 1972 and listed on Euronext Growth Milan. Produces incontinence aids, dialysis products, surgical instruments, advanced wound care, and cardiovascular devices across five sub-brands for hospitals, clinics, and home-care patients via ~400 employees.
Ownership category
akta.pro rank

SVAS Biosana industry classification

Industry
Product category
Medical Devices
NAICS
Surgical and Medical Instrument Manufacturing (339112), Surgical Appliance and Supplies Manufacturing (339113)
SIC
Surgical & Medical Instruments & Apparatus (3841), Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842)
akta.pro industry
PRIMARYHSABAKAH
Incontinence & Urological Supplies (Catheters, Briefs, Ostomy Supplies)
Home & Personal Services/Elder Care & In-Home Care Services/Medical Equipment & Home Mobility Support Services
SECONDARYCRADALAF
Adult Incontinence Products
Consumer Products & Retail/Consumer Packaged Goods (CPG) Manufacturing & Brands/Paper Goods & Disposables (Tissue, Diapers, Feminine Care)
SECONDARYCRADAMAK
Personal Medical Devices & Home Diagnostics (Thermometers, Blood Pressure Monitors, Glucose Meters, Rapid Tests)
Consumer Products & Retail/Consumer Packaged Goods (CPG) Manufacturing & Brands/Health & Hygiene OTC Consumer Goods (First Aid, Oral Care, Personal Health)

Keywords

  • Medical devices manufacturing
  • Pharmaceutical products
  • Peritoneal dialysis supplies
  • Surgical instruments
  • Wound care dressings

Where SVAS Biosana is headquartered

Location

Headquarters

HQ city
Somma Vesuviana
HQ country
Italy
HQ region
Europe

Offices3 records

Markets served

SVAS Biosana business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

  1. Medical Devices Manufacturing and Distribution: Production and distribution of medical devices across multiple product lines including incontinence aids, dialysis products, surgical instruments, orthopedic devices, and advanced wound care products to healthcare providers

Go-to-market motion1 record

Distribution channels2 records

Marketing channels4 records

SVAS Biosana product offering

Product offering

Core offering

SVAS Biosana plans, manufactures, and markets medical devices and pharmaceutical products across five business lines covering incontinence aids, peritoneal dialysis products, custom surgical packs and advanced wound dressings, cardiovascular implants and contrast agents, and cardiac/vascular surgery devices. The company operates three production sites in Italy and distributes medical devices to healthcare providers in Italy and international markets, supplemented by proprietary mobile applications (SVAS myDDT for courier management and SVAS myCare for patient delivery tracking).

Product overview

SVAS Biosana is a multi-brand medical device company comprising five product sub-brands — FARMEX (incontinence aids and personal care), SVAS (peritoneal dialysis and drug transfer devices), MEDICAL (custom surgical packs and advanced dressings), MARK MEDICAL (cardiovascular implants and contrast agents), and BORMIA (cardiac/vascular surgery and neuroradiology devices) — complemented by two digital mobile applications (SVAS myDDT for courier delivery management and SVAS myCare for patient delivery tracking), all integrated through the mySAD Web backend system. The company also operates two acquired Serbian distributors (Hermes Pharma and Megapharm) following its EUR 7 million acquisition in March 2025. SVAS Biosana listed on Euronext Growth Milan in December 2021 and operates 3 production sites in Italy with a workforce of approximately 400 employees across multiple countries.

Differentiator

Problem solved

Functional benefit

Brands

  • FARMEX: Incontinence aids, medical treatments, cotton and personal care products
  • SVAS
  • MEDICAL
  • MARK MEDICAL
  • BORMIA

Products and services

  • FARMEX

Companies that use SVAS Biosana

Customer profile

Named customers1 record

Segments2 records

Ideal customer profiles1 record

SVAS Biosana technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature5 records

SVAS Biosana partnerships and signals

Strategic signal

Partnerships

Two partnerships are on record, tiered core.

  • Hermes PharmacoreStrategic or Co-development Partner · 25 March 2025Serbian medical device distributor based in Belgrade, acquired by Svas Biosana for EUR 3.75 million. Part of strategic expansion in Serbian market.
  • MegapharmcoreStrategic or Co-development Partner · 25 March 2025Serbian medical device distributor based in Belgrade, acquired by Svas Biosana for EUR 3.25 million. Part of strategic expansion in Serbian market.

Scale indicators5 records

Recent moves7 records

Expansion highlights5 records

SVAS Biosana competitors and assessment

Company assessment

Direct peers

  • HARTMANN: German medical and hygiene products company with strong positions in wound care, incontinence management, and surgical supplies. Comparable to SVAS Biosana across multiple product lines and in European mid-tier medical device distribution.
  • Diaverum: European renal care services and dialysis products provider operating across multiple countries. Comparable to SVAS Biosana's peritoneal dialysis offering and represents a potential cross-border partner or competitor in the European dialysis device market.
  • Coloplast: Danish medical device company specializing in ostomy, continence, wound care, and skin health products. Directly comparable to SVAS Biosana's FARMEX incontinence and MEDICAL wound care lines, with overlapping chronic-care customer segments and similar European hospital distribution model.
  • ConvaTec: UK-based medical products company focused on advanced wound care, ostomy, continence, and infusion care. Closely comparable to SVAS Biosana's FARMEX and MEDICAL sub-brands, particularly in incontinence and advanced wound dressings sold through hospital and home-care channels.

Broad incumbents

  • Becton Dickinson: Global medical technology company with a broad portfolio of medical devices, surgical instruments, and injection systems. Comparable to SVAS Biosana in serving hospitals and healthcare providers with multi-category device offerings, though at substantially greater scale and with deeper international reach.
  • Mölnlycke Health Care: Swedish medical device company specializing in wound care and surgical solutions. Comparable to SVAS Biosana's MEDICAL sub-brand (advanced wound dressings and surgical packs) and shares a similar European mid-market hospital sales motion.
  • Smith & Nephew: Global medical technology company with portfolios in advanced wound management, orthopedics, and sports medicine. Comparable to SVAS Biosana's MARK MEDICAL orthopedic prosthesis line and MEDICAL wound care products, though operating at multinational scale.
  • Medtronic: Global medical device leader with significant exposure to cardiovascular, cardiac surgery, and endovascular procedures. Comparable to SVAS Biosana's BORMIA (cardiac/vascular surgery, neuroradiology) and MARK MEDICAL (stents, heart valves) sub-brands, though operating at vastly greater scale and clinical evidence depth.
  • Fresenius Medical Care: Global leader in dialysis products and services. Comparable to SVAS Biosana's SVAS sub-brand for peritoneal dialysis products, though at global scale with vertically integrated dialysis clinic operations.

Regional players

  • Artsana Group: Italian consumer health and personal care company (parent of Chicco, Pic Solution, and Lycia). Comparable as an Italian-headquartered healthcare products company with personal care and medical device adjacencies overlapping with SVAS Biosana's FARMEX incontinence and personal care lines.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

SVAS Biosana social profiles

Digital presence

SVAS Biosana compliance and trust

Trust signal

Compliance9 records

SVAS Biosana financial estimates

Financial estimate

Revenue estimate

Valuation estimate

SVAS Biosana leadership team

Management profile

Number of profiles

Profiles2 records

SVAS Biosana subsidiaries and ownership

Company hierarchy

Subsidiaries2 records

SVAS Biosana funding detail

Funding detail

Funding overview

Funding rounds2 records

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

SVAS Biosana M&A and investment

M&A and investment

M&A1 record

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about SVAS Biosana

What does SVAS Biosana do?

SVAS Biosana plans, manufactures, and markets medical devices and pharmaceutical products across five business lines covering incontinence aids, peritoneal dialysis products, custom surgical packs and advanced wound dressings, cardiovascular implants and contrast agents, and cardiac/vascular surgery devices. The company operates three production sites in Italy and distributes medical devices to healthcare providers in Italy and international markets, supplemented by proprietary mobile applications (SVAS myDDT for courier management and SVAS myCare for patient delivery tracking).

Is SVAS Biosana a public or private company?

SVAS Biosana is a public company. It is classified as public and is currently operating.

When was SVAS Biosana founded?

SVAS Biosana was founded in 1972. It employs 101 to 250 people.

Where is SVAS Biosana based?

SVAS Biosana is headquartered in Somma Vesuviana, Italy, in the Europe region.

How does SVAS Biosana make money?

One revenue line is on record: medical Devices Manufacturing and Distribution.

Who are SVAS Biosana's main competitors?

Direct peers on record are HARTMANN, Diaverum, Coloplast and ConvaTec. Broad incumbents are Becton Dickinson, Mölnlycke Health Care, Smith & Nephew, Medtronic and Fresenius Medical Care. Artsana Group is listed as a regional player.

Does SVAS Biosana have an API?

No public API is recorded for SVAS Biosana.

What industry is SVAS Biosana in?

SVAS Biosana's product category is Medical Devices. Its primary akta.pro industry code is HSABAKAH, Incontinence & Urological Supplies (Catheters, Briefs, Ostomy Supplies), with a secondary code of CRADALAF, Adult Incontinence Products. Its NAICS code is 339112 and its SIC code is 3841.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
MarketScreenerFutures point to weak opening as markets trade in the redFutures indicate a weak market opening on Friday, with the FTSE MIB expected to drop 0.2% or 77.5 points, while London remains flat. The sentiment follows Trump's signal that a deal with Iran is very close, and a multinational force deployment in the Strait of Hormuz is being evaluated.MarketScreenerMilan leads European gains at the open; BPM ralliesEuropean indices opened higher on Thursday, with Milan leading, as investors weighed a potential US-Iran truce. The FTSE Mib rose 0.5% to 48,415.84, while Banco BPM led blue-chip gains at 4.0%. The UK economy expanded 0.5% in Q1, and Brent crude surpassed $95.tenderiNew acquisition in Serbian pharma – Italians buy two Belgrade-based distributors for EUR 7 million in totalSvas Biosana completed acquisitions of Serbian distributors Hermes Pharma and Megapharm for EUR 7 million total, including variable earn-outs. Hermes Pharma reported 2024 revenue of 665 million dinars and profit of 92 million dinars, while Megapharm reported 344 million dinars revenue and 51 million dinars profit.Il Sole 24 ORESvas Biosana: finalizzate acquisizioni di Hermes Pharma e MegapharmSvas Biosana completed acquisitions of Hermes Pharma and Megapharm, with conditions met. Hermes Pharma was bought for €3.5 million plus an earn-out of about €250,000, while Megapharm was acquired for €3 million plus a similar earn-out. Both were financed with Svas's own funds.MarketScreenerSvas Biosana finances growth with two bonds for EUR13 millionSvas Biosana has secured financing for its growth through the issuance of two bonds totaling EUR13 million. The company, an Italy-based manufacturer of medical devices and pharmaceutical products, utilized this capital to support its operational divisions. This financial move aims to strengthen the subsidiary's market position within the Svas group.SoldionlineSvas Biosana emette due bond con scadenza nel 2029Svas Biosana and its subsidiary Mark Medical have issued two unsecured bonds totaling 13 million euros, maturing in December 2029. The funds will finance a new production facility in Italy for incontinence aids and expand commercial presence in Eastern Europe.PR NewswireEquashield and Svas Biosana Propel CSTD Growth in ItalyEquashield announced that its Italian distributor, Svas Biosana, has increased Equashield's CSTD (Closed System Transfer Device) penetration in Italian hospitals, having transitioned major institutions including Ospedale S.Camillo Roma, Ospedale S.Eugenio Roma, Ospedale Civico di Palermo, and Ospedale SS.Annunziata Chieti. The growth has been driven by Italian legislative decree 81 (2008) and EU Directive 98/24/EC, which mandate closed systems for hazardous drug handling to protect healthcare workers. Equashield's VP expressed confidence that Svas Biosana will continue educating the market on hazardous drug protection standards.PR NewswireEquashield e Svas Biosana favoriscono la crescita dei CSTD in ItaliaEquashield, a leading provider of Closed System Transfer Devices (CSTD) for hazardous drugs, announced that its Italian distributor Svas Biosana has successfully driven the adoption of Equashield's CSTDs in several major Italian hospitals, including facilities in Rome, Palermo, and Chieti. The five-year collaboration gained momentum from Italy's Decree 81/2008, which mandates employer-provided tools to ensure worker safety and aligns with EU Directive 98/24/CE on chemical agents, positioning Italy as a leader in safe hazardous drug handling practices in Europe. Equashield's products, including the EQUASHIELD II device and EQUASHIELD Pro automated system, have received FDA approval and are used by hundreds of hospitals and clinics worldwide.